0001209191-21-069493.txt : 20211214
0001209191-21-069493.hdr.sgml : 20211214
20211214170023
ACCESSION NUMBER: 0001209191-21-069493
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211213
FILED AS OF DATE: 20211214
DATE AS OF CHANGE: 20211214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abel Robert Lorne
CENTRAL INDEX KEY: 0001798179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 211491708
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-13
0
0001490978
Schrodinger, Inc.
SDGR
0001798179
Abel Robert Lorne
C/O SCHRODINGER, INC.,
1540 BROADWAY, 24TH FLOOR
NEW YORK
NY
10036
0
1
0
0
See Remarks
Common Stock
2021-12-13
4
M
0
15601
17.00
A
15601
D
Common Stock
2021-12-13
4
S
0
13701
36.1951
D
1900
D
Common Stock
2021-12-13
4
S
0
1900
36.8821
D
0
D
Stock Option (right to buy)
17.00
2021-12-13
4
M
0
15601
0.00
D
2030-02-05
Common Stock
15601
94756
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.77 to $36.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.78 to $36.99, inclusive.
This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.
EVP, Chief Computational Scientist, Head of Modeling R&D
/s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel
2021-12-14